Stock listing
A2P4GU Stock Price, News, Filings & Events — Cardiff Oncology, Inc.
Selected listing: A2P4GU · LSX · EUR · DE
This page tracks Cardiff Oncology, Inc.'s A2P4GU:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P4GU:LSX. A2P4GU:LSX is the stock-level entry point for investors researching Cardiff Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cardiff Oncology, Inc. (CRDF) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- A2P4GU:LSX
- Asset type
- Stock
- Market cap
- $94.1M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LSX
- Currency
- EUR
Cardiff Oncology, Inc. A2P4GU:LSX stock context
This page tracks Cardiff Oncology, Inc.'s A2P4GU:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P4GU:LSX. A2P4GU:LSX is the stock-level entry point for investors researching Cardiff Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cardiff Oncology, Inc. (CRDF) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Cardiff Oncology, Inc.
Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
September 14, 2026
Cardiff Oncology to Participate in September 2026 Conferences
September 2, 2026
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
August 11, 2026
Cardiff Oncology Announces $10 Million Registered Direct Offering
July 15, 2026
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RA...
June 2, 2026
Cardiff Oncology, Inc. earnings calls
Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call
February 27, 2025 · Replay with transcript and chapters
Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call
August 8, 2024 · Replay with transcript and chapters
Cardiff Oncology, Inc. (CRDF) Q1 2024 Earnings Call
May 2, 2024 · Replay with transcript and chapters
Cardiff Oncology, Inc. (CRDF) Q4 2023 Earnings Call
February 29, 2024 · Replay with transcript and chapters
Cardiff Oncology, Inc. (CRDF) Q3 2023 Earnings Call
November 2, 2023 · Replay with transcript and chapters
Research Cardiff Oncology, Inc.
Cardiff Oncology, Inc. investor report
Review AI stock analysis and investor report context for A2P4GU:LSX.
Cardiff Oncology, Inc. company profile
View the public company page for Cardiff Oncology, Inc. on 6ix.
Cardiff Oncology, Inc. news
Read company news and market updates connected to Cardiff Oncology, Inc..
Cardiff Oncology, Inc. investor events
Find investor webinars, events, and replay context for Cardiff Oncology, Inc..
Alternate listings
CRDF:NASDAQ
US · USD
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
XE7C:GETTEX
DE · EUR
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
CRDF:BOATS
US · USD
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
A2P4GU:LS
DE · EUR
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
XE7C:FWB
DE · EUR
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
XE7C:DUS
DE · EUR
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
XE7C:MUN
DE · EUR
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
XE7C:SWB
DE · EUR
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.
XE7C:TRADEGATE
DE · EUR
Alternate listing for Cardiff Oncology, Inc.; the primary context on this page is A2P4GU:LSX.